General Statement of Disclosure:
CONSULTING FEES/HONORARIA: Novartis- EP(MODEST) RESEARCH/RESEARCH GRANTS: Endotronix Inc/ Edwards LifeSciences(NONE) OTHER FINANCIAL BENEFIT: Abbott Medical (MODEST), Boston Scientific(MODEST), Biotronik(MODEST), Johnson and Johnson(MODEST), Bristol-Myers Squibb Company (NONE), Cytokinetics(NONE)
